RADIOIODINE THERAPY IN THYROID CARCINOMA AT RANGPUR,BANGLADESH
Keywords:
Radioiodine therapy, thyroid carcinomaAbstract
OBJECTIVE : To show the usefulness and success of small doses of radioiodine I131 in the treatment of well-differentiated thyroid carcinoma.
MATERIALS & METHODS: Since 1990,in the small town Rangpur in North-west Bangladesh we are using radioactive iodine uptake (RAIU), isotope scanning ( I131 and Tc-99m) and ultrasonography of thyroid nodules.In 1998,we started radioassay of thyroid hormones (T3 & T4) and thyrotropin (TSH). About 6500 patients were tested for suspected thyroid problems. We have given post - thyroidectmy radioiodine therapy using small doses (Table 1) to six patients (M3,F3) with clinical improvements in the follow - ups.
RESULTS: Initial results are encouraging as shown in Table 1.
CONCLUSION : We feel broad-based long-term study should be done to optimize the dose schedule of radioiodine therapy.
Downloads
Metrics
References
Kim EE, Haynie TP. Nuclear Diagnostic Imaging: Practical Clinical Applications. MacMillan New York,1987.
Mazzaferri E. Management of a solitary thyroid nodule. N Engl J Med 1993 ; 328 : 553-559.
Carroll B. Asymptomatic thyroid nodules: incidental sonographic detection. AJR Am J Roentgenol 1982; 138 : 499-501.
Woestyn J, Afschrift M, Schelstraete K, Vermeulen A. Demonstration of nodules in the normal thyroid by echography. BrJ Radiol 1985 ; 58: 1179-1182.
Brander A, Viikinkoski V, Nickels J, Kivisaari L. Importance of thyroid abnormalities detected at US screening : a 5-year follow-up. Radiology 2000; 215: 801-806.
Mortenson J, Woolner L, Bennett W. Gross and microscopic findings in clinically normal thyroid glands. J Clin Endocrinol Metab 1955; 15 : 1270-1280.
Cochand - Priollet B, Guillausseau P- J, Chagnon S, etal. The diagnostic value of fine-needle aspiration biopsy under ultrasonography in nonfunctional thyroid nodules : aprospective study comparing cytologic and histologic findings. Am J Med 1994; 97: 152-157.
Pacella C, Guglielmi R, Fabbrini R etal. Papillary carcinoma in small hypoechoic thyroid nodules, predictive value of echo color Doppler evaluation : preliminary results.J Exp Clin Cancer Res 1998 ; 17: 127-128.
Marqusee E, Benson C, Frates M, et al. Usefulness of ultrasonography in the management of nodular thyroid disease. Ann Intern Med 2000 ; 133 : 696-700.
Rago T, Vitti P, Chiovato S, etal. Role of conventional ultrasonography and color flow - Doppler sonography in predicting malignancy in “cold” thyroid nodules. EurJ Endocrinol 1998; 138 : 41- 46.
Shimamoto K, Endo T, Ishigaki T, Sakuma S, Makino N. Thyroid nodules: evaluation with color Doppler ultrasonography. J Ultrasound Med 1993; 12 : 673- 678.
Kerr L. High-resolution thyroid ultrasound: the value of color Doppler. Ultrasound Q 1994 ; 12: 21-43.
Clark K, JJ C, Scola F. Color Doppler sonography: anatomic and_ physiologic assessment of the thyroid. J Clin Ultrasound 1995 ; 23 : 215-223.
Cerbone G, Spiezia S, Colao A,et al. Power Doppler improves the diagnostic accuracy of color Doppler ultrasonography in cold thyroid nodules : follow-up results. Horm Res 1999;52: 19-24.
Frates MC, Benson CB, Doubilet PM, Cibas ES, Marqusee E. Can color Doppler sonography aid in the prediction of malignancy of thyroid nodules? J Ultrasound Med 2003 ; 22 : 127-131.
Keston AS, Ball RP, Frantz VK etal. Storage of radioactive iodine in a metastasis from thyroid carcinoma. Science 1942; 95 : 362.
Nisa L, Yasmeen S, Haque FS, Karim MA. Salivary gland tumor after radioiodine therapy for well- differentiated thyroid carcinoma : a case report.Bang.JNM 2002 ; 5 : 32-33.
Yasmeen S, Haque FS, Karim MA, Thyroid emergencies following radioiodine therapy: two case reports. Bang. JNM 2002,5:34 -35.
Allweiss P etal. Sialadenitis following I131 therapy for thyroid carcinoma: concise communication.J Nucl Med 1984 ; 25 : 755.
Edmonds CJ, Tellez M. Hyperthyroidism and thyroid cancer. Clin Endocrinol 1988; 28 : 253.
Johansen K et al. Comparison of 1073 MBq and 3700 MBq Iodine131 in postoperative ablation of residual thyroid tissue in patients with differentiated thyroid cancer. J Nucl Med 1991 ; 32 : 252-254.
Nemec J, Rohling S, Zamrazil V, Pohunkova D. Comparison of the distribution of diagnostic and thyroablative I131 in the evaluation of differentiated thyroid cancer. J Nucl Med 1979; 20 : 92-97.
Spies WG, Wojtowicz CH, Spies SM, Shah AY, Zimmer AM Value of post -therapy whole-body I131 imaging in the evaluation of patients with thyroid carcinoma having undergone high-dose I'*!' therapy Clin Nucl Med 1989 ; 14 : 793-800.
Achong DM, Oates E, Lee SL, Doherty F J, Gallbladder visnalization during post-therapy lodine131 imaging of thyroid carcinomaJ Nucl Med 1991 ; 32 : 2275-2277.
Grigsby P. Cost minimization analysis and utility of pretreatment and post treatment total body I131 scan in patients with thyroid carcinoma.Cancer 1998 ; 82 : 931-935.
Arad E, Flannery K, Wilson G, O’MaraR. Fractionated doses of radioiodine for ablation of postsurgical thyroid tissue remnants.Clin Nucl Med 1990; 15: 676.
Arad E, O’Mara RE, Wilson GA. Ablation of remaining functioning thyroid lobe with radioiodine after hemithyroidectomy for carcinoma. Clin Nucl Med 1993; 18 : 662 -663.
Rudavsky AZ, Fine EJ, Freeman LM etal. The effectiveness and regulatory conformity of ambulatory divided dose administration of I131 for thyroid remnant ablation after surgery for thyroid cancer. In Freeman LM (ed.) Nuclear Medicine Annual. New York, Raven Press, 1993, pp.223-232.
Massino ED. etal. Differentiated thyroid carcinoma in children and adolescents. A 37 year experience in 85 patients. J Nucl Med 1997 ; 38 : 669-675.
Edmonds CJ, Smith T. The long-term hazards of the treatment of thyroid cancer with radioiodine. Br J Radiol 1986; 59 » 45-51.
Hall P. Holm LE, Lundell GE. Cancer risks in thyroid cencer patients. Br J Cancer 1992 ; 64: 159-163.
Datz FL. Cerebral edema following iodine 131 therapy for thyroid carcinoma metastatic to the brain. J Nucl Med 1986; 27 : 637-640.
Beierwaltes WH. Therapy of thyroid carcinoma with I131. In Spencer RP et al. (eds.): Radionuclides in therapy. CRC Press, Inc. Boca Raton, Florida, 1987. pp. 19--45.
Clarke SEM. Thyroid disease. In Maisey MN, Britton KE, Collier BD (eds.) : Clinical Nuclear Medicine 3rd ed. 1998, Chapman & Hall, London pp.9-25.
Pacini F, Gasperi M, Fugazzola L, Ceccarelli C, Lippi F, Centoni R, Martino E, Pinchera A. Testicular function in patients with differentiated thyroid carcinoma treated with radioiodine. J Nucl Med 1994; 35: 1418 -22.
Benua RS, Cieale NR, Sonnenberg M. The relation of radioiodine dose to results and complications in the treatment of metastatic thyroid cancer.Am J Roentgenol Radiat Ther Nucl Med 1962 ; 87: 171-182.
Leeper RD. The effect of I131 therapy on survival of patients with metastatic papillary or follicular thyroid carcinoma. J Clin Endocrinol Metab 1973 ; 6: 143.
Harbert J. The thyroid.In Harbert J,da Rocha AFG: Textbook of Nuclear Medicine vol. II pp. 3-52, 2nd ed. 1984, Lea & Febiger, Philadelphia.
Maxon III H. The role of I131 in the treatment of thyroid cancer. Thyroid today 1993;16:1-9.
Jixiao M. The application of18 F-FDG PET imaging on endocrinal tumors. 2002 Hong Kong College of Radiologists 10th Annual Scientific Meeting pp.59-64.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 The ASEAN Journal of Radiology
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Disclosure Forms and Copyright Agreements
All authors listed on the manuscript must complete both the electronic copyright agreement. (in the case of acceptance)
